Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors

Carcinogenesis

Volumn 27, Issue 4, 2006, Pages 848-855

  Lu, Shu ^a   Shen, Kate ^a   Wang, Yaolin ^b   Santner, Steven J ^a   Chen, Jie ^c   Brooks, S C ^a   Wang, Y Alan ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; CARCINOGEN; DIMETHYLBENZ[A]ANTHRACENE; PROTEIN P53; RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA TELANGIECTASIA; AUTOSOMAL RECESSIVE DISORDER; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CELL SURVIVAL; CONGENIC ANIMAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET; ENVIRONMENTAL EXPOSURE; GENE MUTATION; GENOMIC INSTABILITY; HETEROZYGOTE; HYPOTHESIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION RESPONSE; RADIOSENSITIVITY; RELATIVE; SIGNAL TRANSDUCTION; WILD TYPE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BREAST NEOPLASMS; CARCINOGENS; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; ENVIRONMENTAL POLLUTANTS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; MAMMARY NEOPLASMS, ANIMAL; MICE; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 33645308792     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi302     Document Type: Article

References (53)

1. Concannon,P. (2002) ATM heterozygosity and cancer risk. Nat. Genet., 32, 89-90.
2. Hall,J. (2005) The ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants. Cancer Let, 227,105-114.
3. Shiloh,Y. (2003) ATM and related protein kinases: Safeguarding genome integrity. Nat. Rev. Cancer, 3, 155-168.
4. Vo,Q.N., Kim,W.J., Cvitanovic,L., Boudreau,D.A., Ginzinger,D.G. and Brown,K.D. (2004) The ATM gene is a target for epigenetic silencing in locally advanced breast cancer. Oncogene, 23, 9432-9437.
5. Thorstenson,Y.R. and Roxas,A. and Kroiss,R. et al. (2003) Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Res., 63, 3325-3333.
6. Athma,P., Rappaport,R. and Swift,M. (1996) Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet. Cytogenet., 92, 130-134.
7. Geoffroy-Perez,B., Janin,N., Ossian,K. et al. (2001) Cancer risk in heterozygotes for ataxia-telangiectasia. Int. J. Cancer, 93, 288-293.
8. Inskip,H.M., Kinlen,L.J., Taylor,A.M., Woods,C.G. and Arlett,C.F. (1999) Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia. Br. J. Cancer, 79, 1304-1307.
9. Janin,N., Andrieu,N., Ossian,K., Lauge,A., Croquette,M.F., Griscelli,C., Debre,M., Bressac-de-Paillerets,B., Aurias,A. and Stoppa-Lyonnet,D. (1999) Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families. Br. J. Cancer, 80, 1042-1045.
10. Olsen,J.H., Hahnemann,J.M., Borresen-Dale,A.L. et al. (2001) Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. [see comment]. J. Natl Cancer Inst, 93, 121-127.
11. Olsen,J.H., Hahnemann,J.M., Borresen-Dale,A.L. et al. (2005) Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia. Br. J. Cancer, 93, 260-265.
12. Thompson,D., Duedal,S., Kirner,J., McGuffog,L., Last,J., Reiman,A., Byrd,P., Taylor,M. and Easton,D.F. (2005) Cancer risks and mortality in heterozygous ATM mutation carvers. J. Natl Cancer Inst., 97, 813-822.
13. Barlow,C., Eckhaus,M.A., Schaffer,A.A. and Wynshaw-Boris,A. (1999) Atm haploinsufficiency results in increased sensitivity to sublethal doses of ionizing radiation in mice. Nat. Genet., 21, 359-360.
14. Worgul,B.V., Smilenov,L., Brenner,D.J., Junk,A., Zhou,W. and Hall,E.J. (2002) Atm heterozygous mice are more sensitive to radiation-induced cataracts than are their wild-type counterparts. Proc. Natl Acad. Sci. USA, 99, 9836-9839.
15. Gatti,R.A., Tward,A. and Concannon,P. (1999) Cancer risk in ATM heterozygotes: A model of phenotypic and mechanistic differences between missense and truncating mutations. Mol. Genet. Metab., 68, 419-423.
16. Meyn,M.S. (1999) Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene. Clini. Genet., 55, 289-304.
17. Herzog,K.H., Chong,M.J., Kapsetaki,M., Morgan,J.I. and McKinnon,P.J. (1998) Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science, 280, 1089-1091.
18. Xu,Y., Ashley,T., Brainerd,E.E., Bronson,R.T., Meyn,M.S. and Baltimore,D. (1996) Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. [see comment]. Genes Dev., 10, 2411-2422.
19. Barlow,C., Hirotsune,S., Paylor,R. et al. (1996) Atm-deficient mice: A paradigm of ataxia telangiectasia. Cell, 86, 159-171.
20. Elson,A., Wang,Y., Daugherty,C.J., Morton,C.C., Zhou,F., Campos-Torres,J. and Leder,P. (1996) Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc. Natl Acad. Sci. USA, 93, 13084-13089.
21. Lydon,J.P., Ge,G., Kittrell,F.S., Medina,D. and O'Malley,B.W. (1999) Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res., 59, 4276-4284.
22. Wang,Y., Shen,K., Wang,Y. and Brooks,S.C. (2005) Retinoic acid signaling is required for proper morphogenesis of mammary gland. Dev. Dyn., 234, 892-899.
23. Shen,K., Heng,H., Wang,Y., Lu,S., Liu,G., Deng,C.X., Brooks,S.C. and Wang,Y.A. (2005) Atm and p21 cooperate to suppress aneuploidy and subsequent tumor development. Cancer Res., 65, 8747-8753.
24. Nagase,H., Mao,J.H. and Balmain,A. (2003) Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice. Cancer Res., 63, 4849-4853.
25. Soule,H.D., Maloney,T.M., Wolman,S.R., Peterson,W.D.,Jr, Brenz,R., McGrath,C.M., Russo,J., Pauley,R.J., Jones,R.F. and Brooks,S.C. (1990) Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res., 50, 6075-6086.
26. Xu,B., Kim,S.T., Lim,D.S. and Kastan,M.B. (2002) Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol. Cell. Biol., 22, 1049-1059.
27. Yoo,H.Y., Shevchenko,A. and Dunphy,W.G. (2004) Mcm2 is a direct substrate of ATM and ATR during DNA damage and DNA replication checkpoint responses. J. Biol. Chem., 279, 53353-53364.
28. Cortez,D., Glick,G. and Elledge,S.J. (2004) Minichromosome maintenance proteins are direct targets of the ATM and ATR checkpoint kinases. [see comment]. Proc. Natl Acad. Sci. USA, 101, 10078-10083.
29. Yazdi,P.T., Wang,Y., Zhao,S., Patel,N., Lee,E.Y. and Qin,J. (2002) SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev., 16, 571-582.
30. Kim,S.T., Xu,B. and Kastan,M.B. (2002) Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage. Genes Dev., 16, 560-570.
31. Mao,J.H., To,M.D., Perez-Losada,J., Wu,D., Del Rosario,R. and Balmain,A. (2004) Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression. Genes Dev., 18, 1800-1805.
32. Kito,K., Kihana,T., Sugita,A., Murao,S., Akehi,S., Sato,M., Tachibana,M., Kimura,S. and Ueda,N. (1996) Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas. Mol. Carcinog., 17, 78-83.
33. Kumar,R., Medina,D. and Sukumar,S. (1990) Activation of H-ras oncogenes in preneoplastic mouse mammary tissues. Oncogene, 5, 1271-1277.
34. Qing,W.G., Conti,C.J., LaBate,M., Johnston,D., Slaga,T.J. and MacLeod,M.C. (1997) Induction of mammary cancer and lymphoma by multiple, low oral doses of 7,12-dimethylbenz[a]anthracene in SENCAR mice. Carcinogenesis, 18, 553-559.
35. Weil,M.M., Kittrell,F.S., Yu,Y., McCarthy,M., Zabriskie,R.C. and Ullrich,R.L. (2001) Radiation induces genomic instability and mammary ductal dysplasia in Atm heterozygous mice. Oncogene, 20, 4409-4411.
36. Chenevix-Trench,G., Spurdle,A.B., Gatei,M. et al. (2002) Dominant negative ATM mutations in breast cancer families. [see comment] [erratum appears in J Natl Cancer Inst 2002 Jun 19; 94: 952]. J Natl Cancer Inst, 94, 205-215.
37. Szabo,C.I., Schutte,M., Broeks,A. et al. (2004) Are ATM mutations 7271T→G and IVS10-6T→G really high-risk breast cancer-susceptibility alleles? Cancer Res., 64, 840-843.
38. Bernstein,J.L., Bernstein,L., Thompson,W.D. et al. (2003) ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer. Br. J. Cancer, 89, 1513-1516.
39. Teraoka,S.N., Malone,K.E., Doody,D.R., Suter,N.M., Ostrander,E.A., Daling,J.R. and Concannon,P. (2001) Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history. Cancer, 92, 479-487.
40. Chen,J., Birkholtz,G.G., Lindblom,P., Rubio,C. and Lindblom,A. (1998) The role of ataxia-telangiectasia heterozygotes in familial breast cancer. Cancer Res., 58, 1376-1379.
41. FitzGerald,M.G., Bean,J.M., Hegde,S.R., Unsal,H., MacDonald,D.J., Harkin,D.P., Finkelstein,D.M., Isselbacher,K.J. and Haber,D.A. (1997) Heterozygous ATM mutations do not contribute to early onset of breast cancer. [see comment]. Nat. Genet., 15, 307-310.
42. Spring,K., Cross,S., Li,C. et al. (2001) Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636de19 common mutation exhibit a variant phenotype. Cancer Res., 61, 4561-4568.
43. Spring,K., Ahangari,F., Scott,S.P. et al. (2002) Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer. [see comment]. Nat. Genet., 32, 185-190.
44. Karabinis,M.E., Larson,D., Barlow,C., Wynshaw-Boris,A. and Moser,A.R. (2001) Heterozygosity for a mutation in Brca1 or Atm does not increase susceptibility to ENU-induced mammary tumors in Apc(Min)/+ mice. Carcinogenesis, 22, 343-346.
45. Umesaka,S., Fujisawa,K., Sayoko,L. et al. (2005) Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice. Breast Cancer Res., 7, R164-R170.
46. Safe,S., Wormke,M. and Samudio,I. (2000) Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells. J. Mammary Gland Biol. Neoplasia, 5, 295-306.
47. Klinge,C.M., Bowers,J.L., Kulakosky,P.C., Kamboj,K.K. and Swanson,H.I. (1999) The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements. Mol. Cell. Endocrinol., 157, 105-119.
48. Balmain,A., Ramsden,M., Bowden,G.T. and Smith,J. (1984) Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature, 307, 658-660.
49. Quintanilla,M., Brown,K., Ramsden,M. and Balmain,A. (1986) Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature, 322, 78-80.
50. Bardelli,A., Cahill,D.P., Lederer,G., Speicher,M.R., Kinzler,K.W., Vogelstein,B. and Lengauer,C. (2001) Carcinogen-specific induction of genetic instability. [see comment]. Proc. Natl Acad Sci. USA, 98, 5770-5775.
51. Li,R., Yerganian,G., Duesberg,P., Kraemer,A., Willer,A., Rausch,C. and Hehlmann,R. (1997) Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells. Proc. Natl Acad. Sci. USA, 94, 14506-14511.
52. Kuhne,M., Riballo,E., Rief,N., Rothkamm,K., Jeggo,P.A. and Lobrich,M. (2004) A double-strand break repair defect in ATM-deficient cells contributes to radiosensitivity. Cancer Res., 64, 500-508.
53. Angele,S., Romestaing,P., Moullan,N. et al. (2003) ATM haplotypes and cellular response to DNA damage: Association with breast cancer risk and clinical radiosensitivity. Cancer Res, 63, 8717-8725.